AngioDynamics, Inc. (ANGO) Return on equity 2017–2026
AngioDynamics, Inc. (ANGO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-21.5%FY2026 · since FY2017: 1.0% → -21.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -21.5% | -2.9 pp |
| FY2025 | -18.6% | +71.1 pp |
| FY2024 | -89.7% | -75.8 pp |
| FY2023 | -13.9% | -7.6 pp |
| FY2022 | -6.3% | +0.9 pp |
| FY2021 | -7.2% | +29.5 pp |
| FY2020 | -36.7% | -46.6 pp |
| FY2019 | 10.0% | +7.0 pp |
| FY2018 | 3.0% | +2.0 pp |
| FY2017 | 1.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Gross marginANGO Operating incomeANGO Operating marginANGO Operating cash flowANGO Free cash flowANGO Capital expendituresANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →